Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Interim Results on Efficacy, Safety and Quality of Life of an International, Multicenter Prospective, Randomized, Trial

Esther Natalie Olíva, Roberto Latagliata, Caterina Alati et al.|Blood|2015

Cited by 13